Paradigm Biocapital Advisors LP

Q4 2024 13F Holdings

  • Location
    new york, NY
  • Num holdings

    28

  • Value ($000)

    $2,874,092

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001855655
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
NUVL
NUVL

NUVALENT INC

COM
670703107
$419.85 M
15 %

5,363,379

ACLX
ACLX

ARCELLX INC

COMMON STOCK
03940C100
$335.26 M
12 %

4,371,601

ARGX
ARGX

ARGENX SE

SPONSORED ADR
04016X101
$296.00 M
10 %

481,305

RVMD
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$286.63 M
10 %

6,553,111

JANX
JANX

JANUX THERAPEUTICS INC

COM
47103J105
$188.25 M
7 %

3,515,986

TARS
TARS

TARSUS PHARMACEUTICALS INC

COM
87650L103
$140.19 M
5 %

2,531,896

EWTX
EWTX

EDGEWISE THERAPEUTICS INC

COM
28036F105
$119.99 M
4 %

4,493,929

PCVX
PCVX

VAXCYTE INC

COM
92243G108
$116.47 M
4 %

1,422,787

BGNE
BGNE

BEIGENE LTD

SPONSORED ADR
07725L102
$113.79 M
4 %

616,024

CRNX
CRNX

CRINETICS PHARMACEUTICALS IN

COM
22663K107
$97.70 M
3 %

1,910,761

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 28